Rho kinase inhibitors (Scripps)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRho kinase inhibitors (Scripps)
Drug Alias NameSR-3850
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 2
Therapy Area/IndicationsHypertensionGlaucomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsHypertensionGlaucomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A